| Q25256334 | A Chronic Fatigue Syndrome - related proteome in human cerebrospinal fluid |
| Q33553299 | A proteomic approach for the diagnosis of bacterial meningitis |
| Q38653383 | A user's guide for α-synuclein biomarker studies in biological fluids: Perianalytical considerations |
| Q26749307 | Albumin and multiple sclerosis |
| Q37682703 | Apolipoproteins and their subspecies in human cerebrospinal fluid and plasma. |
| Q28479033 | Assessment of α-synuclein secretion in mouse and human brain parenchyma |
| Q43488684 | Association of plasminogen activators and matrix metalloproteinase-9 proteolytic cascade with blood-CNS barrier damage of angiostrongyliasis |
| Q33706403 | Barrier dysfunction or drainage reduction: differentiating causes of CSF protein increase. |
| Q34078026 | Blood and CSF Biomarker Dynamics in Multiple Sclerosis: Implications for Data Interpretation |
| Q93051143 | Blood-Brain Barrier and Delivery of Protein and Gene Therapeutics to Brain |
| Q40455681 | Blood-CSF barrier and compartmentalization of CNS cellular immune response in HIV infection. |
| Q36568768 | Brain penetration of the OAB drug trospium chloride is not increased in aged mice |
| Q36089122 | CSF Levels of Angiopoietin-2 Do Not Differ between Patients with CSF Fluid Leakage Syndrome and Controls. |
| Q52149695 | CSF flow pathways through the ventricle-cistern interfaces in kaolin-induced hydrocephalus rats-laboratory investigation. |
| Q43094846 | CSF/serum quotient graphs for the evaluation of intrathecal C4 synthesis |
| Q36140894 | Cerebrospinal Fluid Inflammatory Biomarkers Reflect Clinical Severity in Huntington's Disease |
| Q89539316 | Cerebrospinal Fluid and Photobiomodulation Effects on Neural Gene Expression in Dental Pulp Stem Cells |
| Q90544282 | Cerebrospinal fluid biomarkers link toxic astrogliosis and microglial activation to multiple sclerosis severity |
| Q36284128 | Cerebrospinal fluid biomarkers of infantile congenital hydrocephalus |
| Q37364236 | Cerebrospinal fluid penetration of meropenem in neurocritical care patients with proven or suspected ventriculitis: a prospective observational study. |
| Q33803741 | Cerebrospinal fluid secretory Ca2+-dependent phospholipase A2 activity is increased in Alzheimer disease |
| Q42072241 | Comparison of major immunoglobulins intrathecal synthesis patterns in Ecuadorian and Cuban patients with angiostrongyliasis. |
| Q34078408 | Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid |
| Q88965227 | Control of Feeding Behavior by Cerebral Ventricular Volume Transmission of Melanin-Concentrating Hormone |
| Q36413268 | Diffusion-weighted magnetic resonance imaging in the assessment of choroid plexus aging |
| Q28540483 | Effects of blood contamination and the rostro-caudal gradient on the human cerebrospinal fluid proteome |
| Q89555286 | Growth differentiation factor 15 is increased in stable MS |
| Q42155799 | High blood pressure effects on the blood to cerebrospinal fluid barrier and cerebrospinal fluid protein composition: a two-dimensional electrophoresis study in spontaneously hypertensive rats. |
| Q33355985 | Human microglial cells synthesize albumin in brain |
| Q27330499 | In vitro study of cerebrospinal fluid dynamics in a shaken basal cistern after experimental subarachnoid hemorrhage |
| Q33525762 | In-depth exploration of cerebrospinal fluid by combining peptide ligand library treatment and label-free protein quantification |
| Q89554272 | Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient |
| Q89513250 | Influence of Blood-Brain Barrier Integrity on Brain Protein Biomarker Clearance in Severe Traumatic Brain Injury: A Longitudinal Prospective Study |
| Q40404031 | Intrathecal synthesis of IgE in children with eosinophilic meningoencephalitis caused by Angiostrongylus cantonensis. |
| Q35080927 | Investigating the association of ApoE genotypes with blood-brain barrier dysfunction measured by cerebrospinal fluid-serum albumin ratio in a cohort of patients with different types of dementia |
| Q92663060 | Ketogenic diet ameliorates axonal defects and promotes myelination in Pelizaeus-Merzbacher disease |
| Q36055674 | Kinetic modelling of serum S100b after traumatic brain injury. |
| Q90388244 | Localization, Occurrence, and CSF Changes of SP-G, a New Surface Active Protein with Assumable Immunoregulatory Functions in the CNS |
| Q98163568 | Location matters: highly divergent protein levels in samples from different CNS compartments in a clinical trial of rituximab for progressive MS |
| Q41524538 | Mannan-binding lectin in cerebrospinal fluid: a leptomeningeal protein |
| Q46535873 | Narcolepsy increased L-PGDS (beta-trace) levels correlate with excessive daytime sleepiness but not with cataplexy |
| Q57824929 | Nitrosative stress indices in dogs with neurological form of canine distemper |
| Q38247035 | Pharmacokinetics and pharmacodynamics of antiretrovirals in the central nervous system |
| Q92770889 | Plasma and Cerebrospinal Fluid Beta-Endorphin Levels Show a Strong Association in Children with Cerebral Malaria |
| Q38862534 | Plasma neuronal specific enolase: a potential stage diagnostic marker in human African trypanosomiasis |
| Q92766222 | Prion protein quantification in human cerebrospinal fluid as a tool for prion disease drug development |
| Q60049283 | Protein variability in cerebrospinal fluid and its possible implications for neurological protein biomarker research |
| Q93054511 | Proteomic Analysis of Cerebrospinal Fluid From Patients With Extranodal NK-/T-Cell Lymphoma of Nasal-Type With Ethmoidal Sinus Metastasis |
| Q47151942 | Proteomic changes in cerebrospinal fluid from primary central nervous system lymphoma patients are associated with protein ectodomain shedding |
| Q48476896 | Recruited leukocytes and local synthesis account for increased matrix metalloproteinase-9 activity in cerebrospinal fluid of dogs with central nervous system neoplasm |
| Q33898968 | Reduced CSF turnover and decreased ventricular Aβ42 levels are related |
| Q34965754 | Reduced cerebrospinal fluid ethanolamine concentration in major depressive disorder |
| Q33880669 | Reibergram of intrathecal synthesis of C4 in patients with eosinophilic meningitis caused by Angiostrongylus cantonensis |
| Q48925554 | Release of brain-type and heart-type fatty acid-binding proteins in serum after acute ischaemic stroke |
| Q83061537 | Rostrocaudal dynamics of CSF biomarkers |
| Q36657804 | Serum Concentrations of S100B are not Affected by Cycling to Exhaustion With or Without Vibration |
| Q37290664 | Serum S100B represents a new biomarker for mood disorders |
| Q36252544 | Single versus Serial Measurements of Neuron-Specific Enolase and Prediction of Poor Neurological Outcome in Persistently Unconscious Patients after Out-Of-Hospital Cardiac Arrest - A TTM-Trial Substudy |
| Q34474577 | Stage progression and neurological symptoms in Trypanosoma brucei rhodesiense sleeping sickness: role of the CNS inflammatory response |
| Q35004738 | Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases |
| Q99711312 | The Challenge of Assessing Mild Neuroinflammation in Severe Mental Disorders |
| Q27307127 | The brain response to peripheral insulin declines with age: a contribution of the blood-brain barrier? |
| Q26853347 | The potential of pathological protein fragmentation in blood-based biomarker development for dementia - with emphasis on Alzheimer's disease |
| Q37692949 | The regulation of brain states by neuroactive substances distributed via the cerebrospinal fluid; a review |
| Q36134872 | Total-tau in cerebrospinal fluid of patients with multiple sclerosis decreases in secondary progressive stage of disease and reflects degree of brain atrophy |
| Q47736742 | Transependymal Cerebrospinal Fluid Flow: Opportunity for Drug Delivery? |
| Q92757163 | Tuberculous meningitis in children is characterized by compartmentalized immune responses and neural excitotoxicity |
| Q44701197 | Use of albumin quotient and IgG index to differentiate blood- vs brain-derived proteins in the cerebrospinal fluid of cats with feline infectious peritonitis |
| Q47417062 | Validation of Ultrasensitive Mutant Huntingtin Detection in Human Cerebrospinal Fluid by Single Molecule Counting Immunoassay |
| Q36226560 | Volume transmission of beta-endorphin via the cerebrospinal fluid; a review |
| Q38831103 | α-Synuclein Aggregates with β-Amyloid or Tau in Human Red Blood Cells: Correlation with Antioxidant Capability and Physical Exercise in Human Healthy Subjects |
| Q51764708 | α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson's Disease Patients and Correlate with Disease Severity. |
| Q36044595 | α-Synuclein in human cerebrospinal fluid is principally derived from neurons of the central nervous system |